NASDAQ:IOVA

Iovance Biotherapeutics Stock Predictions

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

IOVA Prediction Chart

IOVA Predictions History

Latest community submissions for IOVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 11, 2025 $2.54 +14.93% $2.24 V 86.61% 0
Jun 10, 2025 $2.13 -3.55% $2.38 X 89.56% 0
Jun 10, 2025 $2.16 -2.22% $2.38 X 90.80% 0
Jun 10, 2025 $2.21 +0.00% $2.38 X 92.86% 0
Jun 10, 2025 Bullish $2.38 V 1
Jun 9, 2025 $1.97 -3.74% $2.21 X 89.29% 0
Jun 9, 2025 $2.00 -2.34% $2.21 X 90.59% 0
Jun 9, 2025 $2.10 +16.67% $2.21 V 95.02% 1
Jun 4, 2025 $1.74 -4.50% $1.83 X 94.98% 0
Jun 4, 2025 $1.77 -2.81% $1.83 X 96.66% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IOVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE